menu
    • menu

    Company profile for Nanobiotix

    NEW Drugs in Dev: 2
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    "Nanobiotix has been pioneering nanomedicine for more than 17 years to bring a different approach to medicine.Our therapeutic technologies are not based on biology or chemistry – they are based on physical principles at nanoscale. This paradigm shift has allowed us to discover novel approaches to improving treatment outcomes.Our company designs and manufactures nanoparticles that safely enhance the efficacy of radiation ther...
    "Nanobiotix has been pioneering nanomedicine for more than 17 years to bring a different approach to medicine.Our therapeutic technologies are not based on biology or chemistry – they are based on physical principles at nanoscale. This paradigm shift has allowed us to discover novel approaches to improving treatment outcomes.Our company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. With this approach, our ambition is to benefit millions of patients who receive radiation therapy by improving the efficiency of radiation in tumor cells without increasing the dose.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NanobiotixFrance Flag
    Country
    Country
    France
    Address
    Address
    60, rue de Wattignies Bat C PARIS
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nanobiotix.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nanobiotix?trk=tyah&trkInfo=clickedVertical%3Acompany%2CclickedEntityId%3A1749543%2Cidx%3A3-1-3%2CtarId%3A1463671034393%2Ctas%3Ananobiotix
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Nanobiotix

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nanobiotix Prices Oversubscribed €85M Global Offering
    Nanobiotix Prices Oversubscribed €85M Global Offering

    21 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/21/3299513/0/en/nanobiotix-announces-pricing-of-oversubscribed-85m-global-offering.html

    GLOBENEWSWIRE
    21 May 2026
    Share Share
    Nanobiotix Temporarily Halts Trading on Euronext Paris
    Nanobiotix Temporarily Halts Trading on Euronext Paris

    21 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/21/3299023/0/en/nanobiotix-announces-temporary-trading-halt-of-its-ordinary-shares-on-euronext-paris.html

    GLOBENEWSWIRE
    21 May 2026
    Share Share
    Nanobiotix Resumes Trading of Ordinary Shares on Euronext Paris
    Nanobiotix Resumes Trading of Ordinary Shares on Euronext Paris

    21 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/21/3299448/0/en/nanobiotix-announces-trading-resumption-of-its-ordinary-shares-on-euronext-paris.html

    GLOBENEWSWIRE
    21 May 2026
    Share Share
    Nanobiotix Announces Launch Of Global Follow-On Offering
    Nanobiotix Announces Launch Of Global Follow-On Offering

    20 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/20/3298951/0/en/nanobiotix-announces-launch-of-global-follow-on-offering.html

    GLOBENEWSWIRE
    20 May 2026
    Share Share
    Nanobiotix Presents JNJ-1900 Data in Inoperable Lung Cancer
    Nanobiotix Presents JNJ-1900 Data in Inoperable Lung Cancer

    17 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/17/3296239/0/en/nanobiotix-announces-presentation-of-part-1-data-from-a-randomized-phase-2-clinical-trial-evaluating-jnj-1900-nbtxr3-in-stage-3-inoperable-lung-cancer.html

    GLOBENEWSWIRE
    17 May 2026
    Share Share
    Nanobiotix Amends Global Phase 3 Head/Neck Cancer Protocol
    Nanobiotix Amends Global Phase 3 Head/Neck Cancer Protocol

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3287230/0/en/nanobiotix-announces-protocol-amendment-to-ongoing-global-phase-3-head-and-neck-cancer-study.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search